Literature DB >> 1186919

Recovery and conversion of kinins in exsanguinated rat preparations.

J L Prado, E A Limãos, J Roblero, J O Freitas, E S Prado, A C Paiva.   

Abstract

A rat preparation in which the perfusion route bypassed the lungs, which were substituted by an artificial oxygenator, was exsanguinated and perfused with oxygenated 4% dextran (M.W. 70,000) in Tyrode's fluid; a peristaltic pump propelled the perfusing fluid at 20-25 ml/min through the aortic arch and the perfusion medium returned to the right ventricle. Known amounts of bradykinin (BK), kallidin (lysul-bradykinin, LBK) and methionyllysylbradykinin (MLBK) were administered as single injections and samples of the perfusion fluid removed between 1.5 to 6 min following injection. Average total kinin activity remaining in the circulating fluid was calculated from assays on the isolated guinea pig ileum against respective kinin injected and found to be after 3 and 6 min respectively: 20 and 5% for BK, 54 and 21% for LBK, 60 and 30% for MLBK. When the lungs were introduced in the perfusion circuit BK recoveries decreased to 0.4% at 4 min and 0% at 6 min. In 2 experiments 1 mg MLBK and, in another two, 1 mg of LBK were recirculated for 3 to 3.5 min in the rat preparation with lung bypass; enzymic reactions were interrupted in the perfusates after removal by lowering the pH to 4.7 and placing them in a boiling water bath for 5 min. Following proper dilution, kinin activity left in the perfusates was separated on carboxymethylcellulose columns; in 3 experiments about 50% of the activity was identified as BK from its elution position and resistance to trypsin digestion. The average BK-inactivating potency of the perfusate obtained from the rat with lung bypass was 0.3 mug BK/min x ml compared to 16 mug BK/min x ml of rat plasma. The arylamidase activity on arginylnaphthylamide of the perfusate was 2 n moles NA/min x ml and it was about 25-fold lower than that of rat plasma. Rat liver was exsanguinated and perfused in situ through the portal vein and inferior cava vein using the same conditions as for the whole animal. The perfusion rate was 12 ml/min. The recovery of injected BK in this preparation was 40% after 2 min of recirculation, declining progressively in the following minutes. When MLBK was perfused in this preparation for 3 min or glycylarginyllysylbradykinin (GALBK) for 3 and 5 min, significant amounts of BK were found in the perfusates. We conclude that LBK, MLBK and GALBK may be converted at a high rate into BK by tissue aminopeptidases found in the rat preparations used. BK inactivation in the whole rat is a fast reaction, even when the pulmonary tissue is not involved in the inactivation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1186919     DOI: 10.1007/bf00510550

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  The nature of the kallidins released from human plasma by kallikreins and other enzymes.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Pharmacological activity of hypertensin I and its conversion into hypertensin II.

Authors:  E A CARLINI; Z P PICARELLI; J L PRADO
Journal:  Bull Soc Chim Biol (Paris)       Date:  1958

3.  The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases.

Authors:  J A GOLDBARG; A M RUTENBURG
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

4.  Kinin-converting aminopeptidase from human serum.

Authors:  J A Guimarães; D R Borges; E S Prado; J L Prado
Journal:  Biochem Pharmacol       Date:  1973-12-15       Impact factor: 5.858

Review 5.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

6.  Characterization of a kinin-converting arylaminopeptidase from human liver.

Authors:  D R Borges; J L Prado; J A Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Kallidin (lysylbradykinin), the kinin formed from horse plasma by horse urinary kallikrein.

Authors:  E S Prado; M E Webster; J L Prado
Journal:  Biochem Pharmacol       Date:  1971-08       Impact factor: 5.858

8.  Pulmonary extractionof bradykinin and eledoisin.

Authors:  P Biron
Journal:  Rev Can Biol       Date:  1968-03

Review 9.  Present trends of kinin research.

Authors:  M Rocha e Silva
Journal:  Life Sci       Date:  1974-07-01       Impact factor: 5.037

10.  The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-06
View more
  1 in total

1.  Catabolism of vasoactive polypeptides by perfused rat liver.

Authors:  D R Borges; E A Limãos; J L Prado; A C Camargo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.